Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Small-molecule CaVα1⋅CaVβ antagonist suppresses neuronal voltage-gated calcium-channel trafficking.

Chen X, Liu D, Zhou D, Si Y, Xu D, Stamatkin CW, Ghozayel MK, Ripsch MS, Obukhov AG, White FA, Meroueh SO.

Proc Natl Acad Sci U S A. 2018 Nov 6;115(45):E10566-E10575. doi: 10.1073/pnas.1813157115. Epub 2018 Oct 24.

2.

Enhancing excitatory activity of somatosensory cortex alleviates neuropathic pain through regulating homeostatic plasticity.

Xiong W, Ping X, Ripsch MS, Chavez GSC, Hannon HE, Jiang K, Bao C, Jadhav V, Chen L, Chai Z, Ma C, Wu H, Feng J, Blesch A, White FA, Jin X.

Sci Rep. 2017 Oct 6;7(1):12743. doi: 10.1038/s41598-017-12972-6.

3.

Decoy peptide targeted to Toll-IL-1R domain inhibits LPS and TLR4-active metabolite morphine-3 glucuronide sensitization of sensory neurons.

Allette YM, Kim Y, Randolph AL, Smith JA, Ripsch MS, White FA.

Sci Rep. 2017 Jun 16;7(1):3741. doi: 10.1038/s41598-017-03447-9.

4.

Electroacupuncture Promotes Central Nervous System-Dependent Release of Mesenchymal Stem Cells.

Salazar TE, Richardson MR, Beli E, Ripsch MS, George J, Kim Y, Duan Y, Moldovan L, Yan Y, Bhatwadekar A, Jadhav V, Smith JA, McGorray S, Bertone AL, Traktuev DO, March KL, Colon-Perez LM, Avin KG, Sims E, Mund JA, Case J, Deng X, Kim MS, McDavitt B, Boulton ME, Thinschmidt J, Li Calzi S, Fitz SD, Fuchs RK, Warden SJ, McKinley T, Shekhar A, Febo M, Johnson PL, Chang LJ, Gao Z, Kolonin MG, Lai S, Ma J, Dong X, White FA, Xie H, Yoder MC, Grant MB.

Stem Cells. 2017 May;35(5):1303-1315. doi: 10.1002/stem.2613.

5.

Bone Pain Induced by Multiple Myeloma Is Reduced by Targeting V-ATPase and ASIC3.

Hiasa M, Okui T, Allette YM, Ripsch MS, Sun-Wada GH, Wakabayashi H, Roodman GD, White FA, Yoneda T.

Cancer Res. 2017 Mar 15;77(6):1283-1295. doi: 10.1158/0008-5472.CAN-15-3545. Epub 2017 Mar 2.

6.

Sustained relief of ongoing experimental neuropathic pain by a CRMP2 peptide aptamer with low abuse potential.

Xie JY, Chew LA, Yang X, Wang Y, Qu C, Wang Y, Federici LM, Fitz SD, Ripsch MS, Due MR, Moutal A, Khanna M, White FA, Vanderah TW, Johnson PL, Porreca F, Khanna R.

Pain. 2016 Sep;157(9):2124-40. doi: 10.1097/j.pain.0000000000000628.

7.

Impact of Opioid and Nonopioid Drugs on Postsurgical Pain Management in the Rat.

Wilson NM, Ripsch MS, White FA.

Pain Res Treat. 2016;2016:8364762. doi: 10.1155/2016/8364762. Epub 2016 Mar 16.

9.

Carbamazepine potentiates the effectiveness of morphine in a rodent model of neuropathic pain.

Due MR, Yang XF, Allette YM, Randolph AL, Ripsch MS, Wilson SM, Dustrude ET, Khanna R, White FA.

PLoS One. 2014 Sep 15;9(9):e107399. doi: 10.1371/journal.pone.0107399. eCollection 2014.

10.

The HMGB1-RAGE axis mediates traumatic brain injury-induced pulmonary dysfunction in lung transplantation.

Weber DJ, Gracon AS, Ripsch MS, Fisher AJ, Cheon BM, Pandya PH, Vittal R, Capitano ML, Kim Y, Allette YM, Riley AA, McCarthy BP, Territo PR, Hutchins GD, Broxmeyer HE, Sandusky GE, White FA, Wilkes DS.

Sci Transl Med. 2014 Sep 3;6(252):252ra124. doi: 10.1126/scitranslmed.3009443. Retraction in: Sci Transl Med. 2018 Dec 12;10(471):.

11.

Identification of a functional interaction of HMGB1 with Receptor for Advanced Glycation End-products in a model of neuropathic pain.

Allette YM, Due MR, Wilson SM, Feldman P, Ripsch MS, Khanna R, White FA.

Brain Behav Immun. 2014 Nov;42:169-77. doi: 10.1016/j.bbi.2014.06.199. Epub 2014 Jul 8.

12.

Suppression of pain-related behavior in two distinct rodent models of peripheral neuropathy by a homopolyarginine-conjugated CRMP2 peptide.

Ju W, Li Q, Allette YM, Ripsch MS, White FA, Khanna R.

J Neurochem. 2013 Mar;124(6):869-79. doi: 10.1111/jnc.12070. Epub 2013 Jan 20.

13.

Effect of the phosphodiesterase-5 inhibitor zaprinast on ischemia-reperfusion injury in rats.

Polcari AJ, Farooq AV, Woods ME, Ripsch MS, Picken M, Turk TM, White FA.

J Endourol. 2013 Mar;27(3):338-42. doi: 10.1089/end.2012.0198.

14.

Neuroexcitatory effects of morphine-3-glucuronide are dependent on Toll-like receptor 4 signaling.

Due MR, Piekarz AD, Wilson N, Feldman P, Ripsch MS, Chavez S, Yin H, Khanna R, White FA.

J Neuroinflammation. 2012 Aug 16;9:200. doi: 10.1186/1742-2094-9-200.

15.

Inhibition of transmitter release and attenuation of anti-retroviral-associated and tibial nerve injury-related painful peripheral neuropathy by novel synthetic Ca2+ channel peptides.

Wilson SM, Schmutzler BS, Brittain JM, Dustrude ET, Ripsch MS, Pellman JJ, Yeum TS, Hurley JH, Hingtgen CM, White FA, Khanna R.

J Biol Chem. 2012 Oct 12;287(42):35065-77. doi: 10.1074/jbc.M112.378695. Epub 2012 Aug 13.

16.

CRMP-2 peptide mediated decrease of high and low voltage-activated calcium channels, attenuation of nociceptor excitability, and anti-nociception in a model of AIDS therapy-induced painful peripheral neuropathy.

Piekarz AD, Due MR, Khanna M, Wang B, Ripsch MS, Wang R, Meroueh SO, Vasko MR, White FA, Khanna R.

Mol Pain. 2012 Jul 24;8:54. doi: 10.1186/1744-8069-8-54.

17.

The persistent release of HMGB1 contributes to tactile hyperalgesia in a rodent model of neuropathic pain.

Feldman P, Due MR, Ripsch MS, Khanna R, White FA.

J Neuroinflammation. 2012 Jul 23;9:180. doi: 10.1186/1742-2094-9-180.

18.
19.

Further insights into the antinociceptive potential of a peptide disrupting the N-type calcium channel-CRMP-2 signaling complex.

Wilson SM, Brittain JM, Piekarz AD, Ballard CJ, Ripsch MS, Cummins TR, Hurley JH, Khanna M, Hammes NM, Samuels BC, White FA, Khanna R.

Channels (Austin). 2011 Sep-Oct;5(5):449-56. doi: 10.4161/chan.5.5.17363. Epub 2011 Sep 1.

21.

Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca²⁺ channel complex.

Brittain JM, Duarte DB, Wilson SM, Zhu W, Ballard C, Johnson PL, Liu N, Xiong W, Ripsch MS, Wang Y, Fehrenbacher JC, Fitz SD, Khanna M, Park CK, Schmutzler BS, Cheon BM, Due MR, Brustovetsky T, Ashpole NM, Hudmon A, Meroueh SO, Hingtgen CM, Brustovetsky N, Ji RR, Hurley JH, Jin X, Shekhar A, Xu XM, Oxford GS, Vasko MR, White FA, Khanna R.

Nat Med. 2011 Jun 5;17(7):822-9. doi: 10.1038/nm.2345.

22.

Sciatic nerve injury induces functional pro-nociceptive chemokine receptors in bladder-associated primary afferent neurons in the rat.

Foster R, Jung J, Farooq A, McClung C, Ripsch MS, Fitzgerald MP, White FA.

Neuroscience. 2011 Jun 2;183:230-7. doi: 10.1016/j.neuroscience.2011.03.035. Epub 2011 Mar 30.

23.

CXCR4 signaling mediates morphine-induced tactile hyperalgesia.

Wilson NM, Jung H, Ripsch MS, Miller RJ, White FA.

Brain Behav Immun. 2011 Mar;25(3):565-73. doi: 10.1016/j.bbi.2010.12.014. Epub 2010 Dec 28.

24.

Increased chemokine signaling in a model of HIV1-associated peripheral neuropathy.

Bhangoo SK, Ripsch MS, Buchanan DJ, Miller RJ, White FA.

Mol Pain. 2009 Aug 12;5:48. doi: 10.1186/1744-8069-5-48.

25.

Delayed functional expression of neuronal chemokine receptors following focal nerve demyelination in the rat: a mechanism for the development of chronic sensitization of peripheral nociceptors.

Bhangoo S, Ren D, Miller RJ, Henry KJ, Lineswala J, Hamdouchi C, Li B, Monahan PE, Chan DM, Ripsch MS, White FA.

Mol Pain. 2007 Dec 12;3:38.

26.

CXCR4 chemokine receptor signaling mediates pain hypersensitivity in association with antiretroviral toxic neuropathy.

Bhangoo SK, Ren D, Miller RJ, Chan DM, Ripsch MS, Weiss C, McGinnis C, White FA.

Brain Behav Immun. 2007 Jul;21(5):581-91. Epub 2007 Feb 9.

Supplemental Content

Loading ...
Support Center